Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
All Genders
Healthy Volunteers
ID06892340

A Non-Invasive, Non-Sedating Device to Reduce Motion Sickness and Spatial Disorientation in Healthy Adults

Led by 59th Medical Wing · Updated on 2025-08-15

36

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

5

59th Medical Wing

Lead Sponsor

D

Defense Health Agency

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying how a wearable nerve stimulation device called the Sparrow Ascent System12 affects spatial disorientation and motion sickness in healthy adults. Spatial disorientation happens when the body's sense of position conflicts with actual location, involving the inner ear, eyes, body sense, and brain. This can lead to motion sickness, especially in people not used to motion. The device stimulates nerves around the ear that are linked to nausea and other sensations and is already approved by the FDA for other conditions. Participants will be randomly assigned to two groups: one receiving active stimulation from the Sparrow Ascent System12 and the other receiving a sham (inactive) version of the device that looks the same but provides no stimulation. During the study, participants will face motion challenges including tasks in an electronic flight simulator and spinning in a rotating chair while their vital signs are monitored. The stimulation settings can be adjusted for comfort. Throughout the study, participants will undergo tests before, during, and after motion challenges to assess symptoms and performance. These include questionnaires about how they feel, tasks measuring coordination and reaction time, and continuous monitoring of heart rate and blood pressure. The main measure is the Graybiel Scale recorded at multiple times after challenges. The study monitors safety and lasts through the motion challenges and assessments, with data collected up to 90 minutes after.

CONDITIONS

Brief Title

Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation

Who Can Participate

Age: 18Years - 50Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy males and non-pregnant females between 18 and 50 years old
  • Do not experience symptoms of motion sickness
  • English-speaking participants
  • Able to read and understand study procedures to provide informed consent
Not Eligible

You will not qualify if you...

  • Pregnant females
  • Cardiac conditions such as heart failure, history of heart attack, stents, pacemakers, or heart surgery
  • Hypertension requiring daily medication
  • Active vestibular diseases like Meniere's disease or vertigo
  • Neck pain or spinal problems
  • Medications affecting heart, vestibular, or neurological function
  • Recent illness or hospitalization within 30 days
  • Pilots or individuals desensitized to motion sickness
  • Use of vestibular suppressing drugs or substances within 24 hours
  • History of epileptic seizures
  • History of neurological diseases or brain injury
  • Abnormal vital signs before the study
  • Presence of implanted devices like pacemakers or cochlear implants
  • Abnormal ear anatomy or ear infection
  • Any other significant disease or condition that may increase risk or affect participation or results

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 1 day

Participants are given a wearable nerve stimulation device, either active or sham, and undergo spatial disorientation and motion sickness challenges including an electronic flight simulator and a rotating chair. Vital signs are monitored continuously during the study day.

1 in-person visit lasting the study day

Trial Site Locations

Total: 1 location

1

Randolph AFB Physiology lab

San Antonio, Texas, United States, 78148

Actively Recruiting

Loading map...

Research Team

I

Isaac D Erbele, MD, ENT

C

Craig D Nowadly, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

StableEyes With Active Neurophysiological Feedback for Motio...

Vestibular Disorder

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome.

Dorothea D Jenkins, Navid Khodaparast, Georgia H O'Leary...

https://pubmed.ncbi.nlm.nih.gov/33762918

Delivering transcutaneous auricular neurostimulation (tAN) to improve symptoms associated with opioid withdrawal: results from a prospective clinical trial.

Carlos F Tirado, Stephanie N Washburn, Alejandro Covalin...

https://pubmed.ncbi.nlm.nih.gov/35978394

Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial (cMPsE02).

S Bauer, H Baier, C Baumgartner...

https://pubmed.ncbi.nlm.nih.gov/27033012

Cervical transcutaneous vagal nerve stimulation (ctVNS) improves human cognitive performance under sleep deprivation stress.

Lindsey K McIntire, R Andy McKinley, Chuck Goodyear...

https://pubmed.ncbi.nlm.nih.gov/34112935